BS Medicine Podcast
Hosted by
James McCormack
and
Mike Allan
These podcasts promote healthy skepticism and critical thinking, with the majority presented in a case-based format.
Listen Now
Recommended Listening
Episode 588: Strategies for initiating insulin in type 2 diabetes
In episode 588, Mike and James invite Émélie Braschi back to the podcast to discuss another tricky area – insulin in type 2 diabetes and how to use it. Do we need to give it once a day, twice a day or maybe no times a day? Tune in to hear about all the evidence. […]...
Episode 587: Mission Slimpossible – Oral GLP-1 agonists for weight loss
In episode 587, Mike and James invite Adrienne Lindblad back to the podcast to go over all the evidence we have for the oral GLP-1 weight loss medications. You know you are going to get lots of questions about these medications so tune in to find out all the numbers around the benefit and potential […]...
Episode 586: It’s time to challenge penicillin allergy labels
In episode 586, Mike and James invite Émélie Braschi back to the podcast to talk about the tricky issue of how to deal with a potential penicillin allergy. Believe it or not there are a couple of RCTs looking at this issue. These two trials compared oral challenge alone to skin testing followed (if negative) […]...
Episode 584: Remind me, do medications that target brain amyloid improve my dementia?
In episode 584, Mike and James invite Tina Korownyk back to the podcast to talk about the evidence for amyloid-targeting monoclonal antibodies in mild cognitive impairment or Alzheimer’s dementia. Unfortunately, the evidence shows these medications don’t seem to have a clinically important effect and do have some harms. Have a listen as we give you […]...
Episode 583: Reducing the risk associated with risk calculators – PART II
In episode 583, Mike and James continue to go over the issues associated with using CVD risk calculators. We talk about some of the limitations, how to think about the results and explain the risks and benefits to patients. Show notes PEER Simplified Cardiovascular Decision Aid Incorporation of Shared Decision-Making in International Cardiovascular Guidelines, 2012-2022 […]...
